CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression

Genes and Cancer

Volumn 2, Issue 8, 2011, Pages 771-781

  Louderbough, Jeanne M V ^a   Brown, Jessie A ^a   Nagle, Ray B ^b   Schroeder, Joyce A ^a  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

basal cell; breast cancer; CD44; cell adhesion; mammary gland development; myoepithelial cell; prostate cancer

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPERPLASIA; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CELL ADHESION; CELL INTERACTION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUBERTY;

MUS;

EID: 84859148851     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911428223     Document Type: Article

References (39)

1. Brawer MK,Peehl DM,Stamey TA,Bostwick DG.Keratin immunoreactivity in the benign and neoplastic human prostate.Cancer Res. 1985;45 (8): 3663-7.
2. Deugnier MA,Teuliere J,Faraldo MM,Thiery JP,Glukhova MA.The importance of being a myoepithelial cell.Breast Cancer Res. 2002;4 (6): 224-30.
3. Nagle RB,Hao J,Knox JD,Dalkin BL,Clark V,Cress AE.Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue.Am J Pathol. 1995;146 (6): 1498-507.
4. Srigley JR,Dardick I,Hartwick RW,Klotz L.Basal epithelial cells of human prostate gland are not myoepithelial cells: a comparative immunohistochemical and ultrastructural study with the human salivary gland.Am J Pathol. 1990;136 (4): 957-66.
5. Barsky SH.Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype.Exp Mol Pathol. 2003;74 (2): 113-22.
6. Barsky SH,Karlin NJ.Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.J Mammary Gland Biol Neoplasia. 2005;10 (3): 249-60.
7. Polyak K,Hu M.Do myoepithelial cells hold the key for breast tumor progression?.J Mammary Gland Biol Neoplasia. 2005;10 (3): 231-47.
8. Sternlicht MD,Kedeshian P,Shao ZM,Safarians S,Barsky SH.The human myoepithelial cell is a natural tumor suppressor.Clin Cancer Res. 1997;3 (11): 1949-58.
9. Shao ZM,Nguyen M,Alpaugh ML,O'Connell JT,Barsky SH.The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis.Exp Cell Res. 1998;241 (2): 394-403.
10. Jones JL,Shaw JA,Pringle JH,Walker RA.Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.J Pathol. 2003;201 (4): 562-72.
11. Nguyen M,Lee MC,Wang JL, et al.The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.Oncogene. 2000;19 (31): 3449-59.
12. Gudjonsson T,Ronnov-Jessen L,Villadsen R,Rank F,Bissell MJ,Petersen OW.Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.J Cell Sci. 2002;115 (Pt 1): 39-50.
13. Runswick SK,O'Hare MJ,Jones L,Streuli CH,Garrod DR.Desmosomal adhesion regulates epithelial morphogenesis and cell positioning.Nat Cell Biol. 2001;3 (9): 823-30.
14. Lerwill MF.Current practical applications of diagnostic immunohistochemistry in breast pathology.Am J Surg Pathol. 2004;28 (8): 1076-91.
15. Bourguignon LY.CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.J Mammary Gland Biol Neoplasia. 2001;6 (3): 287-97.
16. Herrlich P,Morrison H,Sleeman J, et al.CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor.Ann N Y Acad Sci. 2000;910:106-18.
17. Lopez JI,Camenisch TD,Stevens MV,Sands BJ,McDonald J,Schroeder JA.CD44 attenuates metastatic invasion during breast cancer progression.Cancer Res. 2005;65 (15): 6755-63.
18. De Marzo AM,Bradshaw C,Sauvageot J,Epstein JI,Miller GJ.CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.Prostate. 1998;34 (3): 162-8.
19. Gao AC,Lou W,Dong JT,Isaacs JT.CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.Cancer Res. 1997;57 (5): 846-9.
20. Liu AY,True LD,LaTray L, et al.Analysis and sorting of prostate cancer cell types by flow cytometry.Prostate. 1999;40 (3): 192-9.
21. Lokeshwar BL,Lokeshwar VB,Block NL.Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.Anticancer Res. 1995;15 (4): 1191-8.
22. Patrawala L,Calhoun T,Schneider-Broussard R, et al.Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.Oncogene. 2006;25 (12): 1696-708.
23. Shipitsin M,Campbell LL,Argani P, et al.Molecular definition of breast tumor heterogeneity.Cancer Cell. 2007;11 (3): 259-73.
24. Bourguignon LY,Zhu H,Chu A,Iida N,Zhang L,Hung MC.Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.J Biol Chem. 1997;272 (44): 27913-8.
25. Berner HS,Suo Z,Risberg B,Villman K,Karlsson MG,Nesland JM.Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.Histopathology. 2003;42 (6): 546-54.
26. Diaz LK,Zhou X,Wright ET, et al.CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.Clin Cancer Res. 2005;11 (9): 3309-14.
27. Schmits R,Filmus J,Gerwin N, et al.CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity.Blood. 1997;90 (6): 2217-33.
28. Yu WH,Woessner JF,McNeish JD,Stamenkovic I.CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.Genes Dev. 2002;16 (3): 307-23.
29. Lin EY,Jones JG,Li P, et al.Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.Am J Pathol. 2003;163 (5): 2113-26.
30. Park SY,Lee HE,Li H,Shipitsin M,Gelman R,Polyak K.Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Clin Cancer Res. 2010;16 (3): 876-87.
31. Weber GF,Bronson RT,Ilagan J,Cantor H,Schmits R,Mak TW.Absence of the CD44 gene prevents sarcoma metastasis.Cancer Res. 2002;62 (8): 2281-6.
32. Verhagen AP,Ramaekers FC,Aalders TW,Schaafsma HE,Debruyne FM,Schalken JA.Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.Cancer Res. 1992;52 (22): 6182-7.
33. Perou CM,Sorlie T,Eisen MB, et al.Molecular portraits of human breast tumours.Nature. 2000;406 (6797): 747-52.
34. Ronnov-Jessen L,Petersen OW,Bissell MJ.Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.Physiol Rev. 1996;76 (1): 69-125.
35. Sainsbury JR,Anderson TJ,Morgan DA.ABC of breast diseases: breast cancer.BMJ. 2000;321 (7263): 745-50.
36. Sorlie T,Perou CM,Tibshirani R, et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proc Natl Acad Sci U S A. 2001;98 (19): 10869-74.
37. Banerjee S,Reis-Filho JS,Ashley S, et al.Basal-like breast carcinomas: clinical outcome and response to chemotherapy.J Clin Pathol. 2006;59 (7): 729-35.
38. Foulkes WD,Brunet JS,Stefansson IM, et al.The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.Cancer Res. 2004;64 (3): 830-5.
39. Pochampalli MR,Bitler BG,Schroeder JA.Transforming growth factor alpha dependent cancer progression is modulated by Muc1.Cancer Res. 2007;67 (14): 6591-8.